Participants 114 146 3
subjects with metabolic syndrome
Participants 320 358 4
subjects with metabolic syndrome (MS).
Participants 359 388 5
Participants with MS (n = 54)
Participants 870 939 5
Forty-two subjects completed the study (placebo, n = 19; WGP, n = 23)
